Ligne de temps

Jeanne Chiaravalli
Ingénieur(e) de Recherche
21 avr. 2023
publication

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages.

Lire plus
22 mars 2023
publication

Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors.

Lire plus
04 juil. 2022
publication

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

Lire plus
17 juin 2022
news

New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2

Lire plus
01 mai 2022
publication

A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors.

Lire plus
21 sept. 2021
publication

Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.

Lire plus
01 sept. 2021
publication

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.

Lire plus
25 mai 2021
publication

Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues.

Lire plus
05 juin 2015
team

Plateforme de Criblage Chémogénomique et Biologique (PF-CCB)

Lire plus